There will be an average drop of almost 20% in the price of 288 medicines from December 1, the Federal Office of Public Health says. Savings of around CHF100 million ($100 million) are expected.
The move comes at a time of debate over the high costs of medicines in Switzerland.
The price reduction, which averages 18.8%, will for example affect Dafalgan (paracetamol), ASS Cardio (aspirin) and children’s oral drops Becetamol. Some medicines will even see a drop in price of up to 30%, with a 50% reductionExternal link for the diuretic Aldactone, a medicine used for high blood pressure.
In a statement on FridayExternal link, the health office said 255 medicines would see no price change because they were “economically sustainable” in Switzerland compared with abroad and with other medicines.
It also took a look at generic medicines, co-marketing medicinesExternal link (same product, different brands) and biosimilars (almost identical copy of original product) and found price reductions could be made in 134 out of 237 cases.
This is the second timeExternal link that the health office has cut the price of medicines, the first time coming at the end of 2017. This has allowed for definite savings in this case of CHF225 million, over 350 medicines, the health office said. This was more than the expected CHF190 million.
Debate
There has been much debate in Switzerland about the cost of medicines. In September the government announced its intention to cap prices for generic drugs as part of a package of measures to reduce rising health costs in Switzerland.
In spring it was revealed that generic drugs cost twice as much in Switzerland as in other parts of Europe. Patented drugs were 9% more expensive, a study found.
Several groups, including the price watchdog, consumer advocates and the umbrella organisation of health insurers, have been calling for years for prices to be reduced.
More
More
What’s being done to bring down high drug costs?
This content was published on
We unravel part of the tangled web of players and factors that influence prices of drugs in the US and Switzerland.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Trump tariffs: ‘I’m a bit perplexed’, says former US ambassador to Switzerland
This content was published on
The former US ambassador to Switzerland, Edward McMullen, says he is optimistic for the Alpine country with regard to the 31% tariff on imports imposed by US President Donald Trump.
Swiss Federal Court upholds Beny Steinmetz’s bribery conviction
This content was published on
Switzerland's highest court has upheld the conviction of French-Israeli mining magnate Beny Steinmetz for bribery of foreign public officials.
This content was published on
The Trump administration has imposed a 31% tariff on imports from Switzerland. Swiss President Karin Keller-Sutter has warned against "giving in to alarmism" in an interview published on Saturday,
This content was published on
Scientists have shown that bonobos combine their calls into complex sound sequences that resemble combinations of human words.
This content was published on
US parliamentarians have threatened the UN Human Rights Council with sanctions similar to those against the International Criminal Court (ICC).
This content was published on
Thanks to abundant snowfall, lift operators benefited from increased visitor numbers, with the number of guests jumping by 12% year-on-year.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Costs of generic drugs and outpatient services targeted
This content was published on
The government wants to cap prices for generic drugs as part of a package of measures to reduce rising health costs in Switzerland.
Swiss campaign to make lifesaving drugs affordable
This content was published on
Swiss authorities must act to make lifesaving drugs more affordable by introducing compulsory licensing, says NGO Public Eye.
Meet the man trying to make Switzerland less expensive
This content was published on
Switzerland has an official price watchdog – someone who fights unfair prices that hurt consumers. Where does he see potential for savings?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.